Unity Biotechnology Inc (UBX)
1.18
-0.07
(-5.60%)
USD |
NASDAQ |
Nov 05, 09:37
Unity Biotechnology Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2022 | 0.4948 |
| March 31, 2022 | 0.3821 |
| December 31, 2021 | 0.3603 |
| September 30, 2021 | 0.4345 |
| June 30, 2021 | 0.3776 |
| March 31, 2021 | 0.3089 |
| December 31, 2020 | 0.2957 |
| September 30, 2020 | 0.2478 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.4948
Maximum
Jun 2022
0.2638
Average
0.3089
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.7481 |
| Myomo Inc | 0.00 |
| Catheter Precision Inc | 0.0454 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 53.52M |
| Total Liabilities (Quarterly) | 33.77M |
| Shareholders Equity (Quarterly) | 19.75M |